NL-OMON34870已完成3 期
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentrationcontrolled everolimus in liver transplant recipients. - Long term evaluation of efficacy and safety of Certican versus Prograft.
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- ovartis
- 入组人数
- 28
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •Completed Month 24 visit of core study and continuously being treated with assigned
排除标准
- •1. Patients with clinically significant systemic infection requiring active use of IV
- •antibiotics at Month 24.
- •2. Patients who are in a critical care setting at Month 24 requiring life support measures
- •such as mechanical ventilation, dialysis, requirement of vasopressor agents.
- •3. Women of child-bearing potential, unless they meet certain criteria.
研究者
相似试验
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsEUCTR2009-017311-15-HUovartis Pharma Services AG470
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 14.1Level: LLTClassification code 10066543Term: Acute allograft rejectionSystem Organ Class: 10021428 - Immune system disordersEUCTR2009-017311-15-CZovartis Pharma Services AG470
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 12.1Level: LLTClassification code 10066543Term: Acute allograft rejectionEUCTR2009-017311-15-NLovartis Pharma Services AG470
进行中（未招募）
不适用
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 12.1Level: LLTClassification code 10066543Term: Acute allograft rejectionEUCTR2009-017311-15-IEovartis Pharma Services AG470
进行中（未招募）
1 期
Extension study to the multicenter, open-label, randomized, controlled study CRAD001H2304 to evaluate the long-term efficacy and safety of concentration-controlled everolimus in liver transplant recipientsprophylaxis of liver allograft rejection in liver transplant recipientsMedDRA version: 12.1Level: LLTClassification code 10066543Term: Acute allograft rejectionEUCTR2009-017311-15-BEovartis Pharma Services AG470